Variations in the expression of these genes can causes differences in everything from eye color to blood type to cancer and disease risks. Testing has increased tenfold over the past decade for ...
Certis Oncology Solutions, led by Peter Ellman, President and CEO, is a life science technology company dedicated to realizing the promise of precision oncology. The company’s product is Oncology ...
A Mayo Clinic-led team of researchers is solving one of the most frustrating aspects of genetic cancer screening — results that give zero guidance to patients on whether they are at elevated risk.
If the development of blood vessels in the placenta is impaired, fetal growth retardation may result. Scientists from the German Cancer Research Center (DKFZ) and the Mannheim Medical Faculty of ...